KALVISTA PHARMACEUTICALS INC (KALV)
US4834971032 - Common Stock
| TTM (2024-1-31) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | 2020 (2020-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -108.31M | -92.91M | -82.34M | -46.24M | -29.12M | |||
| Depreciation Amortization | 787.00K | 720.00K | 560.00K | 540.00K | 510.00K | |||
| Change In Working Capital | -313.00K | 7.41M | -12.32M | 8.35M | -20.64M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 11.06M | 9.52M | 15.96M | 7.19M | 4.43M | |||
| OPERATING CASH FLOW | -96.76M | -75.26M | -78.13M | -30.17M | -44.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -391.00K | -1.20M | -930.00K | -80.00K | -220.00K | |||
| Other Investing Activity | 35.65M | 42.61M | 58.79M | -147.57M | 16.97M | |||
| INVESTING CASH FLOW | 35.26M | 41.42M | 57.86M | -147.65M | 16.75M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | N/A | -50.00K | |||
| Stock Issued/Repurchased | 586.00K | 58.12M | 1.58M | 212.12M | 11.64M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 586.00K | 58.12M | 1.58M | 212.12M | 11.58M | |||
| Exchange Rate Effect | -1.07M | 1.24M | -1.17M | 510.00K | 260.00K | |||
| CHANGE IN CASH | -61.98M | 25.52M | -19.86M | 34.81M | -16.23M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -96.76M | -75.26M | -78.13M | -30.17M | -44.82M | |||
| Capital Expenditure | -391.00K | -1.20M | -930.00K | -80.00K | -220.00K | |||
| FREE CASH FLOW | -97.15M | -76.46M | -79.06M | -30.25M | -45.04M | |||
All data in USD